Discover

STAA
STAAR Surgical Company
28.15
2 x 20.80
2 x 36.48
bid
ask
-
0.54
1.88%
2 @ 04:00 PM
28.15 +0.00 (0.00%)
Ytd21.91%
1y65.39%
28.14
day range
29.10
15.59
52 week range
35.87
Open28.58Prev Close28.69Low28.14High29.10Mkt Cap1.40B
Vol446.26KAvg Vol966.25KEPS-0.42P/EN/AForward P/E28.51
Beta1.23Short Ratio6.38Inst. Own113.83%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg28.93200-d Avg24.451yr Est29.67
Earning
DateForEstimateReportedSurprisesurprise %
2026-05-132026-030.13N/AN/AN/A
2026-03-032025-120.160.04-0.12-75.00%
2025-11-052025-090.180.460.28155.56%
2025-08-062025-060N/A0.4987.50%
2025-05-072025-030N/A0.0711.86%
2025-02-112024-120.02N/A-0.52-2.00%
Upgrade / Downgrade
DateFirmActionFromTo
2026-05-29WedbushUpgradeOutperformOutperform
2026-05-15Wells FargoUpgradeEqual-WeightEqual-Weight
2026-05-14Canaccord GenuityUpgradeBuyBuy
2026-05-14Piper SandlerUpgradeNeutralNeutral
2026-05-14StifelUpgradeHoldHold
2026-05-14WedbushUpgradeNeutralOutperform
Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Insider Holder
DateNameRelationQuantityDescription
2026-05-14ANDREWS DEBORAH JChief Executive Officer18.65KStock Award(Grant)
2026-03-12BROADWOOD PARTNERS, L.P.Beneficial Owner of more than 10% of a Class of Security0.00Purchase
2026-06-17BUTCHER ARTHUR CDirector9.55KConversion of Exercise of derivative security
2025-03-04FARRELL STEPHEN CChief Executive Officer35.16KConversion of Exercise of derivative security
2026-05-14FOUST WARRENChief Executive Officer83.11KStock Award(Grant)
2026-06-17JIANG WEIDirector77.13KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Broadwood Capital, Inc.16.12M453.89M32.38%
2026-03-30Blackrock Inc.6.67M187.65M13.39%
2026-03-30Yunqi Capital Ltd3.26M91.69M6.54%
2026-03-30Madison Avenue Partners, LP2.44M68.73M4.90%
2026-03-30Vanguard Portfolio Management LLC2.12M59.78M4.27%
2026-03-30State Street Corporation1.83M51.60M3.68%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-05-30iShares Trust-iShares Core S&P Small-Cap ETF3.01M84.87M6.06%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.10M30.85M2.20%
2026-04-29iShares Trust-iShares Russell 2000 ETF811.22K22.84M1.63%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund799.83K22.52M1.61%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund556.76K15.67M1.12%
2026-05-30SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF458.03K12.89M0.92%
Split
SplitDate
1 : 21992-05-18